
JAMA Editors' Summary
Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more
Aug 6, 2024
10:39
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.